vimarsana.com

Lumicell Direct Visualization System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Approves Lumisight to Detect Residual Cancer After Lumpectomy

The FDA has approved Lumisight (pegulicianine) for use in adults with breast cancer.

FDA Approves Drug-Device Combo to Detect Residual Cancer After Lumpectomy

The FDA has approved Lumisight (pegulicianine), an optical imaging agent, to illuminate residual breast cancer.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.